A Blinded Randomized Clinical Study of RefluxStop™ Compared With Nissen Fundoplication in the Treatment of GERD

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorImplantica CE Reflux Ltd.

About this trial

This study will evaluate if the RefluxStop™ device will treat your acid reflux and improve your symptoms and how it compares to the standard surgical treatment for GERD, the Nissen fundoplication.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Willing and able to provide informed consent and to participate in the clinical investigation;

Age ≥ 18 years or according to local legal age of adulthood at the location of the test site if older;

Documented GERD present for ≥ 12 months. Typical symptoms are defined as heartburn, which is a burning sensation often presented as a substernal pain;

24-hour pH monitoring proven GERD with pH measurement, off PPI therapy for at least 7 days prior to testing. (Total distal esophageal pH must be < 4 for ≥ 4.5% of time during a 24-hour monitoring);

Disqualifiers

> 8 cm sliding hernia and paraesophageal hernia; no mesh is allowed;

Manometry verified lack of or moderate or severe weak peristalsis in esophagus with DCI <300 or pathologic LOS function including hypercontractability, spasm or pathologic nonrelaxing functionality (the latter defined as coordinated swallows in less than 70% of wet swallows or median IRP>15mmHg). Hypercontractability defined as DCI >8'000 or pressure >45 mmHg. Thus, excluding from the study the rare diseases achalasia, scleroderma, and nutcracker esophagus, however, including mild esophageal motility disorder patients with mildly weak peristalsis;

History of bariatric or anti-reflux surgery;

Female subjects who are pregnant or nursing;

Trial design

Design model

Parallel

Treatments tested in this trial

  • RefluxStop™ implantation

    Device

    Standard surgical technique for implantation RefluxStop™, as described in the Instructions for Use

  • Nissen fundoplication

    Procedure/Surgery

    Standard surgical technique for Nissen fundoplication

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: RefluxStop™ device implantationActive comparator 1 intervention
Group B: Nissen fundoplication surgeryActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Patient Reported Outcomes - Side effects (PROS) evaluation

Patient Reported Outcomes - Side effects (PROS) evaluation at 6 months, combining the well-established side effects of traditional surgical treatment methods: * Dysphagia - swallowing difficulties; * Odynophagia - pain at swallowing; * Inability to belch and inability to vomit; and * Worsening of gas bloating compared to baseline;

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: